Eva Šloncová

646 total citations
36 papers, 416 citations indexed

About

Eva Šloncová is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Eva Šloncová has authored 36 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 5 papers in Cancer Research. Recurrent topics in Eva Šloncová's work include Cancer-related gene regulation (10 papers), Wnt/β-catenin signaling in development and cancer (8 papers) and Genetic factors in colorectal cancer (6 papers). Eva Šloncová is often cited by papers focused on Cancer-related gene regulation (10 papers), Wnt/β-catenin signaling in development and cancer (8 papers) and Genetic factors in colorectal cancer (6 papers). Eva Šloncová collaborates with scholars based in Czechia, Russia and Netherlands. Eva Šloncová's co-authors include Martina Vojtěchová, Vladimír Kořínek, Jolana Turečková, Dana Kučerová, Michaela Krausová, Lucie Janečková, Blanka Železná, P Frič, Vı́tězslav Křı́ž and J Vachtenheim and has published in prestigious journals such as Scientific Reports, FEBS Letters and International Journal of Molecular Sciences.

In The Last Decade

Eva Šloncová

36 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Šloncová Czechia 12 236 102 53 52 47 36 416
Xiarong Shi United States 12 325 1.4× 100 1.0× 29 0.5× 49 0.9× 52 1.1× 15 576
Li Wei China 7 150 0.6× 103 1.0× 42 0.8× 32 0.6× 35 0.7× 17 380
Sylvie Prigent France 13 469 2.0× 133 1.3× 39 0.7× 86 1.7× 81 1.7× 17 756
Hongxin Zhang China 16 394 1.7× 88 0.9× 28 0.5× 99 1.9× 86 1.8× 33 561
Maaike C.W. van den Berg Netherlands 9 245 1.0× 49 0.5× 25 0.5× 44 0.8× 118 2.5× 9 461
Christopher M. Gallo United States 7 490 2.1× 68 0.7× 19 0.4× 53 1.0× 17 0.4× 9 696
Xiaoduo Xie China 10 490 2.1× 81 0.8× 52 1.0× 89 1.7× 106 2.3× 18 662
Shiro Kanamori Japan 10 318 1.3× 96 0.9× 25 0.5× 55 1.1× 47 1.0× 14 543
Lionel Le Gallic France 11 249 1.1× 52 0.5× 12 0.2× 26 0.5× 40 0.9× 16 418
Luciana K. Rosselli‐Murai United States 9 213 0.9× 46 0.5× 16 0.3× 50 1.0× 28 0.6× 15 407

Countries citing papers authored by Eva Šloncová

Since Specialization
Citations

This map shows the geographic impact of Eva Šloncová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Šloncová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Šloncová more than expected).

Fields of papers citing papers by Eva Šloncová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Šloncová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Šloncová. The network helps show where Eva Šloncová may publish in the future.

Co-authorship network of co-authors of Eva Šloncová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Šloncová. A scholar is included among the top collaborators of Eva Šloncová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Šloncová. Eva Šloncová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janečková, Lucie, Martina Vojtěchová, Vı́tězslav Křı́ž, et al.. (2022). TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness. Cancers. 14(17). 4137–4137. 9 indexed citations
2.
Janečková, Lucie, Martina Vojtěchová, Eva Šloncová, et al.. (2019). Msx1 loss suppresses formation of the ectopic crypts developed in the Apc-deficient small intestinal epithelium. Scientific Reports. 9(1). 1629–1629. 15 indexed citations
3.
Janečková, Lucie, Lucie Lanikova, Vı́tězslav Křı́ž, et al.. (2018). Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells. Genes. 9(9). 439–439. 31 indexed citations
4.
Janečková, Lucie, Michal Kolář, Lucie Lanikova, et al.. (2016). HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy. Translational Oncology. 9(2). 99–107. 5 indexed citations
5.
Janečková, Lucie, Bohumil Fafílek, Michaela Krausová, et al.. (2016). Wnt Signaling Inhibition Deprives Small Intestinal Stem Cells of Clonogenic Capacity. genesis. 54(3). 101–114. 12 indexed citations
6.
Janečková, Lucie, Vendula Pospíchalová, Bohumil Fafílek, et al.. (2015). HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage–Associated Tumorigenesis. Molecular Cancer Research. 13(7). 1139–1148. 24 indexed citations
7.
Tůmová, Lucie, António Pombinho, Martina Vojtěchová, et al.. (2014). Monensin Inhibits Canonical Wnt Signaling in Human Colorectal Cancer Cells and Suppresses Tumor Growth in Multiple Intestinal Neoplasia Mice. Molecular Cancer Therapeutics. 13(4). 812–822. 49 indexed citations
8.
Pospíchalová, Vendula, Jolana Turečková, Bohumil Fafílek, et al.. (2011). Generation of two modified mouse alleles of the Hic1 tumor suppressor gene. genesis. 49(3). 142–151. 16 indexed citations
9.
Turečková, Jolana, Martina Vojtěchová, Michaela Krausová, Eva Šloncová, & Vladimír Kořínek. (2009). Focal Adhesion Kinase Functions as an Akt Downstream Target in Migration of Colorectal Cancer Cells. Translational Oncology. 2(4). 281–290. 31 indexed citations
10.
Vojtěchová, Martina, et al.. (2008). Regulation of mTORC1 Signaling by Src Kinase Activity Is Akt1-Independent in RSV-Transformed Cells. Neoplasia. 10(2). 99–107. 40 indexed citations
11.
Maletı́nská, Lenka, Jana Maixnerová, Renata Haugvicová, et al.. (2007). Cocaine- and amphetamine-regulated transcript (CART) peptide specific binding in pheochromocytoma cells PC12. European Journal of Pharmacology. 559(2-3). 109–114. 43 indexed citations
12.
Vojtěchová, Martina, et al.. (2006). Regulation of c-Src activity by the expression of wild-type v-Src and its kinase-dead double Y416F-K295N mutant. Archives of Biochemistry and Biophysics. 455(2). 136–143. 7 indexed citations
13.
Vojtěchová, Martina, et al.. (2003). Initiation factor eIF2B not p70 S6 kinase is involved in the activation of the PI‐3K signalling pathway induced by the v‐src oncogene. FEBS Letters. 543(1-3). 81–86. 6 indexed citations
14.
Šloncová, Eva, et al.. (2001). Changes of E-cadherin and β-catenin in Human and Mouse Intestinal Tumours. The Histochemical Journal. 33(1). 13–17. 5 indexed citations
15.
Kučerová, Dana, et al.. (2001). Expression and interaction of different catenins in colorectal carcinoma cells. International Journal of Molecular Medicine. 8(6). 695–8. 3 indexed citations
16.
Frič, P, et al.. (2000). Different expression of some molecular markers in sporadic cancer of the left and right colon. European Journal of Cancer Prevention. 9(4). 265–268. 27 indexed citations
17.
Kučerová, Dana, et al.. (1998). Angiotensin II receptors on colorectal carcinoma cells.. International Journal of Molecular Medicine. 2(5). 593–5. 11 indexed citations
18.
Bubeník, J, et al.. (1997). Tumour vaccines expressing IL-2, CD80, and IL-2 plus CD80 gene. International Journal of Oncology. 11(6). 1213–9. 3 indexed citations
19.
Šloncová, Eva, et al.. (1997). Differences of alkaline phosphatase and arginase activities in human colorectal carcinoma cell lines.. PubMed. 43(3). 101–4. 8 indexed citations
20.
Šloncová, Eva, et al.. (1993). Activity of PDGF (A) gene in the human cell line derived from a renal carcinoma metastasis.. PubMed. 39(1). 40–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiarong Shi Breakdown of academic impact, for papers by Li Wei Breakdown of academic impact, for papers by Sylvie Prigent Breakdown of academic impact, for papers by Hongxin Zhang Breakdown of academic impact, for papers by Maaike C.W. van den Berg Breakdown of academic impact, for papers by Christopher M. Gallo Breakdown of academic impact, for papers by Xiaoduo Xie Breakdown of academic impact, for papers by Shiro Kanamori Breakdown of academic impact, for papers by Lionel Le Gallic Breakdown of academic impact, for papers by Luciana K. Rosselli‐Murai
Rankless by CCL
2026